- Home
- About
- Find staff
- Chaido Chamalidou
Chaido Chamalidou
-
The prognostic value of changes in Ki67 following neoadjuvant chemotherapy in residual triple-negative breast cancer: a Swedish nationwide registry-based
study
Jenny Nyqvist-Streng, Mikael Helou, Khalil Helou, Chaido Chamalidou, Anikó Kovács, Toshima Z Parris
Breast Cancer Research and Treatment - 2025 -
Compliance to adjuvant endocrine therapy and survival in breast cancer
patients
Chaido Chamalidou, Salmir Nasic, Barbro Linderholm
Cancer Treatment and Research Communications - 2023 -
Discordance of PIK3CA and TP53 mutations between breast cancer brain metastases and matched primary
tumors.
Anna Thulin, Carola Andersson, Elisabeth Werner Rönnerman, Shahin De Lara, Chaido Chamalidou, Arnd Schoenfeld, Anikó Kovács, Henrik Fagman, Fredrik Enlund, Barbro Linderholm
Scientific reports - 2021 -
Survival patterns of invasive lobular and invasive ductal breast cancer in a large population-based cohort with two decades of follow
up.
Chaido Chamalidou, H Fohlin, Per Albertsson, L-G Arnesson, Zakaria Einbeigi, Erik Holmberg, A Nordenskjöld, B Nordenskjöld, Per Karlsson, Barbro Linderholm
Breast (Edinburgh, Scotland) - 2021 -
Clinical outcome of patients with brain metastases from breast cancer - A population based study over 21
years.
Anna Thulin, Elisabeth Werner Rönnerman, Chenyang Zhang, Shahin De Lara, Chaido Chamalidou, Arnd Schoenfeldt, Carola Andersson, Anikó Kovács, Fredrik Enlund, Barbro Linderholm
Breast - 2020 -
Compliance to adjuvant endocrine treatment – real world data from 1019 consecutive luminal breast cancer patients with long
follow-up
Chaido Chamalidou, S. Nasic, B. Linderholm
European Journal of Cancer. Vol. 138, Suppl. 1, S59 - 2020